Vimal Patel started his journey at CRL in 2018 as the head of the laboratory sciences department in Reno, NV. For over 4 years he focused on improving processes, culture, and expanding the bioanalytical business. In his current role as Sr. Director of Global Labs, he is responsible for developing global strategies to position CRL’s lab sciences organization for growth. Prior to CRL, he held several positions with increasing responsibilities in business development and as a scientific director of bioanalysis at Amgen, ICON, and Eurofins.
Vimal has a Bachelor of Science in biology from California State University and a Masters of Business Administration from California Lutheran University.
How Modern CROs Accelerate Your Drug Development
Are you facing delays, bottlenecks, or rising costs in your drug development process? In this webinar, you will learn how leading CROs overcome these challenges with innovative strategies. Gain insights that can directly impact your timelines, reduce risks, and streamline your path to approval.
Watch the Replay
eGuide: Bioanalysis from Early-Stage to Clinical Drug Development
Accounting for modality complexity, evolving regulatory expectations, and the critical importance of upfront planning, this eGuide addresses how to identify risks early and align your bioanalytical strategy with the needs of your compound, your timeline, and your team.
Learn More